Cellanova SVF Kit

Cellanova SVF Kit offers a system designed to obtain high mesenchymal stem cell yields without the use of enzymes while providing a significantly faster workflow and substantially lower investment costs compared to enzymatic systems. Discover the future of regenerative therapies with D-MED.

CELLANOVA SVF KIT
CELLANOVA SVF KIT

NOT FAT TISSUE, NON-ENZYMATIC, REAL SVF CELL ISOLATION

Not Fat, Cell Isolation

We do not define the process of making adipose tissue injectable as stem cell therapy. SVF cells are genuinely isolated from the extracellular matrix/tissue for you.

While the final product is rich in nucleated cells, fibrotic tissue, adipocytes, and triglycerides are effectively excluded. In addition, 41 μm filtration applied to the final product helps provide a safer injectable cellular suspension.

Egg cells are circular.
cell drawings

Not a Mechanical, But a Regenerative Effect

Fat injection primarily provides a mechanical volumizing effect due to its structural properties. However, it cannot deliver the same high regenerative potential as concentrated SVF isolation enriched with stem cells.

Stem cells isolated and concentrated from tissue can rapidly proliferate within the body’s natural microenvironment and differentiate into various cell types. Unlike standard fat injection procedures, this approach offers a true regenerative treatment opportunity.

Not Tissue, But Countable Cells

Micronized adipose tissues may contain stem cells; however, this does not mean that SVF cell populations are isolated, purified, or concentrated.

With Cellanova SVF, the final product can be directly visualized under a standard microscope. Furthermore, under fluorescence microscopy, nucleated and non-nucleated cells can be identified, quantified, and their viability can be easily evaluated.

Synovial fluid cells
cell phone double visual minimum
Cellonova my e1766568958600

Cellanova SVF Provides Visible, Measurable Scientific Evidence

Immediately After SVF Cell Isolation
Fluorescence Microscopy Count and Analysis Results

[Total cell] : 4.24 x 107 cells/mL
[Nucleated cell]: 24.2 x 106 cells/mL
[Non-nucleated cell]: 1.89 x 107 cells/mL
Viability of nucleated cell : 92.8% 

Data obtained from samples dated 28 December 2020. Cell counting was performed using the LunaSTEM system, and the report was provided by Seher Üstün Yaylacı, MD, Assoc. Prof.

Not Cultured, Fresh Isolation, Flow Cytometry Data

FITC: CD73 : 61.6%
APC: CD90 : 81.2%
PerCP: CD105 : 2.3%

Flow cytometry analysis was performed to distinguish hematopoietic and endothelial cell populations. Surface antigens including CD34, CD29, CD14, CD11b, and HLA-DR were evaluated using a lineage exclusion strategy, enabling the determination of mesenchymal, endothelial, pericytic, leukocytic, and stromal/progenitor cell fractions in the final product.

Screenshot 2025 12 18 23.19.02
Screenshot 2025 12 18 23.19.20

The study was conducted on samples dated 28 December 2020 by Maia Health Consultancy at Hacettepe University Teknokent. Cell count results were derived from the report of by Seher Üstün Yaylacı, MD, Assoc. Prof. All analyses were performed using the BD FACSCanto II device and BD FACS Diva software.